Jordan Feldman, Rightway CEO
August 28, 2024 09:39 PM EDTUpdated 02:33 PM
Health Tech

How an up­start phar­ma­cy ben­e­fit man­ag­er has been win­ning over com­pa­nies like Tik­Tok and Zoom

Ngai Yeung

Health Tech Reporter

(This sto­ry is from our new Health Tech newslet­ter. If you’d like to sign up, just click here.)

In a mar­ket …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

WuXi AppTec will sell cell and gene ther­a­py busi­ness to pri­vate eq­ui­ty firm

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

A service from the Financial Times